Valued at a market cap of $21 billion, CenterPoint Energy, Inc. (CNP) is a leading energy delivery company specializing in ...

As announced in Statement on Developmental and Regulatory Policies dated February 07, 2025, Reserve Bank of India today placed on its website draft directions on Additional Factor of Authentication ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Investors interested in stocks from the Utility - Electric Power sector have probably already heard of Xcel Energy (XEL) and CenterPoint Energy (CNP). But which of these two companies is the best ...

The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...

Short CNP slightly under 33.35, target 31.34, stop loss @ 33.45 Check the time stamp on this data. Updated AI-Generated Signals for Centerpoint Energy Inc (holding Co) (CNP) available here: CNP. Type ...

The lease is set to expire in 2031. The decision is largely based on that new owners Nirav Patel of CNP DT Hospitality LLC ...

Mizuho Securities analyst Anthony Crowdell has reiterated their neutral stance on CNP stock, giving a Hold rating yesterday.Invest with ...

CenterPoint Energy reaches settlement agreement resulting in lower bills for customers in its 2024 general rate case, ...

Cour Pharmaceuticals Development Co. Inc. has obtained IND clearance from the FDA for CNP-103, a nanoparticle in development to address the underlying autoimmunity of type 1 diabetes. A first-in-human ...